The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20611iti3
The Journal of Experimental Medicine, Vol. 206, No. 11, 2304-2305
The Rockefeller University Press, 0022-1007 $30.00
© Maxmen
This Article
Right arrow Full Text (PDF, 1142K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Maxmen, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxmen, A.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

How staph thwarts attack


Figure 1
Staph infections caused fewer kidney abscesses (arrows) without adsA.

Staphylococcus aureus stifles its host's immune response by producing an immunosuppressive molecule, report Thammavongsa and colleagues.

The new study reveals that without the cell wall enzyme adenosine synthase A (AdsA), most staphylococci fail to thrive and cause severe disease in mice. The gene encoding AdsA contains a 5'-nucleotidase domain, making it similar to a family of mammalian enzymes that convert adenosine monophosphate into adenosine. Adenosine has many immune-dampening effects including blunting T cell proliferation, inhibiting cytokine production, and blocking neutrophil degranulation and superoxide production. Bacterial isolates expressing AdsA were previously associated with invasive disease in humans, but the connection between AdsA and pathogenesis wasn't understood.

Now it appears that at least two strains of staph (including one methicillin-resistant strain) and the anthrax pathogen Bacillus anthracis use AdsA to tap into the adenosine system. Bacteria with intact adsA survived longer in whole blood from rodents and humans than did adsA-deficient bacteria. And mice infected with adsA-deficient strains cleared infection quickly and rarely developed the abscesses characteristic of progressive staph infections. The virulence of adsA-deficient staph could be regained by genetically restoring the enzyme. With AdsA around, adenosine levels were higher, presumably allowing staph to escape destruction by neutrophils.

Manipulating the adenosine pathway may turn out to be a widespread phenomenon, as the authors also identified putative 5'-nucleotidase–encoding genes in a variety of gram-positive bacteria.



Amy Maxmen

amaxmen{at}rockefeller.edu



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Staphylococcus aureus synthesizes adenosine to escape host immune responses
Vilasack Thammavongsa, Justin W. Kern, Dominique M. Missiakas, and Olaf Schneewind
J. Exp. Med. 2009 206: 2417-2427. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 1142K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Maxmen, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxmen, A.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS